TREATMENT OF DISEASES ASSOCIATED WITH ATONAL HOMOLOG 1 (ATON1) BY INHIBITING NATURAL ANTISENSE TRANSCRIPT OF GENE ATON1 Russian patent published in 2016 - IPC C12N15/113 

Abstract RU 2585229 C2

FIELD: medicine.

SUBSTANCE: invention relates to an antisense oligonucleotide, representing a phosphorothioate analogue with length of 19 to 30 nucleotides, which is a compound which hybridises with natural antisense polynucleotide gene atonal homolog 1 (ATON1) and increases expression of said gene ATON1 in vivo or in vitro as compared with normal control. Said oligonucleotide has at least 50% sequence identity with sequence of 19-30 nucleic acids of RNA molecule transcribed from polynucleotide ATON1. Invention also relates to use of said oligonucleotides for treatment of diseases and disorders associated with expression of gene ATON1.

EFFECT: invention widens range of tools aimed at treatment of diseases and disorders associated with expression of gene ATON1.

26 cl, 1 dwg, 1 tbl, 2 ex

Similar patents RU2585229C2

Title Year Author Number
TREATMENT OF DISEASES RELATED WITH GENE DLG BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT OF DLG GENE 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • Kojto Karlos
RU2611190C2
TREATMENT OF DISEASES, ASSOCIATED WITH PROTEIN OF PROSTATE APOPTOTIC RESPONSE PAR4, BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT OF PAR4 GENE 2011
  • Kollard Dzhozef
  • Khorkova Sherman Ol'Ga
RU2575608C2
TREATMENT OF DISEASES ASSOCIATED WITH THE SIALIDASE 4 (NEU4) GENE, BY GENE NEU4 NATURAL ANTISENSE TRANSCRIPT INHIBITION 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2624048C2
TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) ASSOCIATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • Kojto Karlos
RU2611195C2
TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • De Leon Belinda
  • Kojto Karlos
  • Khsyao Dzhejn Kh., Dr.
RU2588654C2
TREATMENT OF ALPHA-L-IDURONIDASE (IDUA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IDUA 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
  • Kojto Karlos
  • Gang Shen
RU2597972C2
TREATMENT OF DISEASES ASSOCIATED WITH METHIONINE SULFOXIDE REDUCTASE A (MSRA), BY MSRA NATURAL ANTISENSE TRANSCRIPT INHIBITION 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2620978C2
TREATMENT OF DISEASES ASSOCIATED WITH FRATAXIN (FXN), BY INHIBITING NATURAL ANTISENSE FXN TRANSCRIPT 2012
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2620980C2
TREATING DISEASES, ASSOCIATED WITH NANOG, BY INHIBITION OF NATURAL ANTISENSE NANOG TRANSCRIPT 2011
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2608493C2
TREATMENT OF DISEASES ASSOCIATED WITH SUBSTRATE OF INSULIN RECEPTOR 2 (IRS2) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 2010
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2616283C2

RU 2 585 229 C2

Authors

Kollard Dzhozef

Khorkova Sherman Olga

Dates

2016-05-27Published

2011-05-25Filed